Kyverna Therapeutics

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company based in Emeryville, United States. Its mission is to liberate autoimmune patients through the curative potential of cell therapy. The company is pioneering a durable disease-clearing approach using CAR T-cell therapy, aiming for deep B cell depletion, an immune system reset, and long-term remission in autoimmune diseases. It has active, ongoing clinical trials for multiple autoimmune diseases at different locations across the world.

Kyverna Therapeutics is a company in Emeryville, United States. It is a patient-centered, clinical-stage biopharmaceutical company with active, ongoing clinical trials for multiple autoimmune diseases at different locations across the world. The company is pioneering a durable disease-clearing approach aiming for deep B cell depletion, an immune system reset, and long-term remission in autoimmune diseases, leveraging the success of CAR T-cell therapies in B cell-driven hematological malignancies.

Patient-centered, clinical-stage biopharmaceutical company pioneering CAR T-cell therapy for autoimmune diseases.

1. 1Kyverna is Developing Cell Therapies for Autoimmune Diseaseskyvernatx.com
2. 2Kyverna Therapeutics, Inc. (United States)wikidata.org